Company / Operating Income
vTv Therapeutics Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$25.5M
FY2025
5-year range
-$25.5M / -$11.9M
FY2021-FY2025
Trend
-13.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has declined for 3 consecutive years, from -$12M in FY2022 to -$26M in FY2025.
Based on SEC 10-K filings.
-$26M in FY2025.
Declined from -$22M to -$26M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- vTv Therapeutics Inc.'s operating income has declined for 3 consecutive years.
- In FY2025, operating income decreased 13.1% year-over-year.
- Peak operating income was recorded in FY2022.
- Lowest operating income in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$25.5M | -13.1% |
| FY2024 | -$22.5M | -4.1% |
| FY2023 | -$21.7M | -82.8% |
| FY2022 | -$11.9M | +43.3% |
| FY2021 | -$20.9M | -5.4% |
| FY2020 | -$19.8M | +60.9% |
| FY2019 | -$50.7M | +7.9% |
| FY2018 | -$55.0M | -44.3% |
| FY2017 | -$38.1M | -32.0% |
| FY2016 | -$28.9M | +19.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026